(Q39732190)

14 September 2017

1 reference

title

Pseudomonas cepacia: biology, mechanisms of virulence, epidemiology (English)

1 reference

14 September 2017

1 reference

Pseudomonas cepacia

1 reference

Goldmann DA

1

1 reference

PubMed ID

3517271

14 September 2017

Klinger JD

series ordinal

2

1 reference

PubMed ID

3517271

14 September 2017

language of work or name

English

0 references

publication date

1 May 1986

1 reference

The Journal of Pediatrics

14 September 2017

1 reference

14 September 2017

108

1 reference

14 September 2017

806-812

1 reference

14 September 2017

5 Pt 2

1 reference

Sputum bacteriology in patients with cystic fibrosis in a Toronto hospital during 1970-1981

14 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2886%2980749-1

Pseudomonas cepacia infection in cystic fibrosis: an emerging problem

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2886%2980749-1

Pseudomonas cepacia colonization in patients with cystic fibrosis: risk factors and clinical outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2886%2980749-1

Emendation of the Description of Pseudomonas cepacia Burkholder (Synonyms: Pseudomonas multivorans Stainer et al., Pseudomonas kingae Jonsson; EO-1 Group)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2886%2980749-1

Pseudomonas cepacia sp. nov., nom. rev.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2886%2980749-1

Nucleic Acid Homologies in the Genus Pseudomonas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2886%2980749-1

Ribosomal Ribonucleic Acid Cistron Similarities of Phytopathogenic Pseudomonas Species

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2886%2980749-1

Foot lesions associated with Pseudomonas cepacia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2886%2980749-1

Pseudomonas cepacia as contaminant and infective agent

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2886%2980749-1

Pseudomonas Cepacia Resistance to Antibacterials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2886%2980749-1

Hospital infection by Pseudomonas cepacia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2886%2980749-1

Pseudobacteremia attributed to contamination of povidone-iodine with Pseudomonas cepacia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2886%2980749-1

Subacute and acute endocarditis due to pseudomonas cepacia in heroin addicts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2886%2980749-1

Pseudomonas Species Bacteremia Caused by Contaminated Normal Human Serum Albumin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2886%2980749-1

Pseudomonas cepacia septicemia in patients with burns: report of two cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2886%2980749-1

Pseudomonas cepacia peritonitis associated with contamination of automatic peritoneal dialysis machines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2886%2980749-1

Necrotizing Pneumonitis Due to the Pseudomonad Eugonic Oxidizer — Group I

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2886%2980749-1

Pseudomonas cepacia pneumonia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2886%2980749-1

Pseudomonas cepacia pneumonia in a child with chronic granulomatous disease and selective IgA deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2886%2980749-1

Bacteremia in patients with cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2886%2980749-1

Antibiotic prophylaxis in cystic fibrosis: inhaled cephaloridine as an adjunct to oral cloxacillin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2886%2980749-1

Purification and properties of a new beta-lactamase from Pseudomonas cepacia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2886%2980749-1

Effects of amantadines on influenza B and measles virus infection in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2886%2980749-1

In Vitro Susceptibility of Pseudomonas cepacia and Pseudomonas maltophilia to Trimethoprim and Trimethoprim-Sulfamethoxazole

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2886%2980749-1

In vitro activities of aztreonam, piperacillin, and ticarcillin combined with amikacin against amikacin-resistant Pseudomonas aeruginosa and P. cepacia isolates from children with cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2886%2980749-1

Comparison of cefpiramide (HR-810) and four anti-pseudomonal beta-lactam agents against pseudomonas isolates from children with cystic fibrosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2886%2980749-1

Occurrence and antimicrobial susceptibility of gram-negative nonfermentative bacilli in cystic fibrosis patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2886%2980749-1

In-vitro activity of ciprofloxacin and other antibacterial agents against Pseudomonas aeruginosa and Pseudomonas cepacia from cystic fibrosis patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2886%2980749-1

Ceftazidime alone and in combination in patients with cystic fibrosis: lack of efficacy in treatment of severe respiratory infections caused by Pseudomonas cepacia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2886%2980749-1

Ceftazidime in cystic fibrosis: pharmacokinetics and therapeutic response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2886%2980749-1

Ceftazidime therapy in patients with cystic fibrosis and multiply-drug-resistant pseudomonas.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2886%2980749-1

[Serological classification of Pseudomonas cepacia]

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2886%2980749-1

Bacteriocin, plasmid and pectolytic diversity in Pseudomonas cepacia of clinical and plant origin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2886%2980749-1

Proposal of a new species Pseudomonas kingii

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2886%2980749-1

Characterization of Pseudomonas cepacia isolates from patients with cystic fibrosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2886%2980749-1

4,9-Dihydroxyphenazine-1,6-dicarboxylic Acid Dimethylester and the 'Missing Link' in Phenazine Biosynthesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2886%2980749-1

Fourteen-year survival of Pseudomonas cepacia in a salts solution preserved with benzalkonium chloride

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2886%2980749-1

7 January 2021

Response of Pseudomonas cepacia to beta-Lactam antibiotics: utilization of penicillin G as the carbon source

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2886%2980749-1

7 January 2021

Cervical osteomyelitis caused by Pseudomonas cepacia in an intravenous-drug abuser

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2886%2980749-1

7 January 2021

Association of Pseudomonas cepacia with chronic granulomatous disease

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2886%2980749-1

7 January 2021

Selective medium for Pseudomonas cepacia containing 9-chloro-9-(4-diethylaminophenyl)-10-phenylacridan and polymyxin B sulfate

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2886%2980749-1

7 January 2021

Efficacy of inhaled tobramycin in the treatment of pulmonary exacerbations in children with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2886%2980749-1

7 January 2021

Imipenem/cilastatin in acute pulmonary exacerbations of cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2886%2980749-1

7 January 2021

O and H serotyping of Pseudomonas cepacia

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2886%2980749-1

7 January 2021

In vitro inhibition of lymphocyte proliferation by Pseudomonas aeruginosa phenazine pigments.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2886%2980749-1

7 January 2021

Evaluation of a new polyvalent Pseudomonas vaccine in respiratory infections

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2886%2980749-1

7 January 2021

10.1016/S0022-3476(86)80749-1

Identifiers

DOI

1 reference

14 September 2017

1 reference

PubMed ID

3517271